PRODUCTS 产品服务
invivoCrown IV0107替换BioXCell BE0273

invivoCrown IV0107替换BioXCell BE0273

InVivoPro Anti-Mouse PD-1(CD279) in vivo antibody, Clone 29F.1A12 ...

invivoCrown IV0101替换BioXCell BE0101

invivoCrown IV0101替换BioXCell BE0101

InVivoPro Anti-Mouse PD-L1(B7-H1, CD274) in vivo antibody, Clone 10F.9G2 ...

invivoCrown IV0109替换BioXCell BE0164

invivoCrown IV0109替换BioXCell BE0164

InVivoPro Anti-Mouse CTLA-4 (CD152) in vivo antibody, Clone 9D9 ...

invivoCrown IV0102替换BioXCell BE0003-1

invivoCrown IV0102替换BioXCell BE0003-1

InVivoPro Anti-Mouse CD4 in vivo antibody, Clone GK1.5 ...

ABOUT US
艾美捷科技,作为国际知名供应商在中国区10年以上的金牌代理商和独家代理商,是中国国内最早提出专注和专业服务于科研经销商,为经销商伙伴提供一站式服务(科研类订单转介绍/当地市场分析/销售团队组建/各个区域品牌代理授权/技术售前和售后/市场营销资料共享/供应商合作开发)的密切合作伙伴。 艾美捷科
NEWS 新闻中心
ProSci.jpg

ProSci Incorporated从事抗体等科研试剂的研发、生产和销售。公司现拥有17000多种单、多克隆抗体,产品涵盖了细胞凋亡、信号转导、免疫、肿瘤、细胞生物、神经生物、传染病等领域。公司的抗体大都经免疫亲和层析纯化,具有高纯度、高亲和力、特异性强等特点,所有的ProSci抗体都经过了严格的验证测试和质量控制,已保证高质量的产品。ProSci的抗体广销於世界30多个国家和地区,得到欧美日等生物医学界科研人员和生物制药公司的研发人员的广泛接受。ProSci直销的产品和ProSci的名字已在520多篇科研论文中出现了1500多次,ProSci的经销商和客户都对ProSci产品的质量和服务十分满意。我们的抗体可用于免疫印迹(Western blot) ,免疫组织化学(IHC),免疫细胞化学(ICC),酶联免疫吸附实验(ELISA)和细胞流式分析(FACS)等方面。此外,ProSci还提供标记二抗,重组蛋白,细胞和组织裂解液,细胞涂片,组织切片,多肽等产品与抗体配套使用。ProSci在美国拥有完整的免疫学试剂开发、生产、检测的生产线,包括自己的厂房和实验动物基地,可为您的研究提供信得过的抗体等科研试剂。

 

ProSci Incorporated is a privately-held biotechnology firm located in San Diego, California. A leader in its field, ProSci’s priority is to provide the highest quality monoclonal, polyclonal, and single domain antibody services in the industry. ProSci’s expertise in antibody production, immunochemistry services, and biological research is realized through customizable services, innovative products, competitive pricing, high-quality research tools, and unparalleled technical support.

 

ProSci的主要产品包括:

Primary Antibodies

Secondary Antibodies

Recombinant Proteins

Lysates

Antibody Beads

Control Antibodies

Detection Sets

Immunoblots

Peptides

Reagents

Slides

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" alt="ProSci ">

ProSci

DATE: 2025-12-14 12:36

Mediomics.jpg

Mediomics公司2001年成立,致力于为学术机构、制药公司、医学研究者、环境研究者提供创新性的检测试剂盒及生物感应物质。Mediomics拥有Patented Bridge-It® Assay Platform、Patented FRET-PINCER® Assay Platform、Patented TRF-PINCER® Assay Platform三大技术平台。

 

Mediomics, LLC provides innovative assay kits and biosensors needed by academic research laboratories, point of care testing, pharmaceutical companies, as well as medical and environmental research markets.  

 

Technology platforms:

(1)Patented Bridge-It® Assay Platform

Bridge-It® Assays are optimized to measure DNA binding proteins, their ligands, and co-regulators. Mediomics’ Bridge-It® assay was based on a simple idea of splitting the DNA binding site for a protein into two DNA half-sites. The presence of the DNA-binding protein or one of its ligands can be detected by FRET (fluorescence resonance energy transfer).

(2)Patented FRET-PINCER® Assay Platform

FRET-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples. The patent-protected FRET-PINCER® Assay system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light through FRET (fluorescence resonance energy transfer).

(3)Patented TRF-PINCER® Assay Platform

TRF-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples. The patent-protected TRF-PINCER® Assay platform system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light with Time-Resolved Fluorometry (TRF) sensitivity.

 

主要产品线包括:

(1)Bridge-It® Assay

(2)TR-FRET Bridge-It® Assay

(3)FRET-PINCER® Assay

(4)TR-FRET PINCER®Assay

(5)Other

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

< " alt="Mediomics ">

Mediomics

DATE: 2025-12-14 10:43